Cargando…

Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes

Antigenic variation in the globular domain of influenza A virus (IAV) hemagglutinin (HA) precludes effective immunity to this major human pathogen. Although the HA stem is highly conserved between influenza virus strains, HA stem-reactive antibodies (StRAbs) were long considered biologically inert....

Descripción completa

Detalles Bibliográficos
Autores principales: Magadán, Javier G., Altman, Meghan O., Ince, William L., Hickman, Heather D., Stevens, James, Chevalier, Aaron, Baker, David, Wilson, Patrick C., Ahmed, Rafi, Bennink, Jack R., Yewdell, Jonathan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055778/
https://www.ncbi.nlm.nih.gov/pubmed/24945804
http://dx.doi.org/10.1371/journal.ppat.1004204
_version_ 1782320725200207872
author Magadán, Javier G.
Altman, Meghan O.
Ince, William L.
Hickman, Heather D.
Stevens, James
Chevalier, Aaron
Baker, David
Wilson, Patrick C.
Ahmed, Rafi
Bennink, Jack R.
Yewdell, Jonathan W.
author_facet Magadán, Javier G.
Altman, Meghan O.
Ince, William L.
Hickman, Heather D.
Stevens, James
Chevalier, Aaron
Baker, David
Wilson, Patrick C.
Ahmed, Rafi
Bennink, Jack R.
Yewdell, Jonathan W.
author_sort Magadán, Javier G.
collection PubMed
description Antigenic variation in the globular domain of influenza A virus (IAV) hemagglutinin (HA) precludes effective immunity to this major human pathogen. Although the HA stem is highly conserved between influenza virus strains, HA stem-reactive antibodies (StRAbs) were long considered biologically inert. It is now clear, however, that StRAbs reduce viral replication in animal models and protect against pathogenicity and death, supporting the potential of HA stem-based immunogens as drift-resistant vaccines. Optimally designing StRAb-inducing immunogens and understanding StRAb effector functions require thorough comprehension of HA stem structure and antigenicity. Here, we study the biogenesis of HA stem epitopes recognized in cells infected with various drifted IAV H1N1 strains using mouse and human StRAbs. Using a novel immunofluorescence (IF)-based assay, we find that human StRAbs bind monomeric HA in the endoplasmic reticulum (ER) and trimerized HA in the Golgi complex (GC) with similar high avidity, potentially good news for producing effective monomeric HA stem immunogens. Though HA stem epitopes are nestled among several N-linked oligosaccharides, glycosylation is not required for full antigenicity. Rather, as N-linked glycans increase in size during intracellular transport of HA through the GC, StRAb binding becomes temperature-sensitive, binding poorly to HA at 4°C and well at 37°C. A de novo designed, 65-residue protein binds the mature HA stem independently of temperature, consistent with a lack of N-linked oligosaccharide steric hindrance due to its small size. Likewise, StRAbs bind recombinant HA carrying simple N-linked glycans in a temperature-independent manner. Chemical cross-linking experiments show that N-linked oligosaccharides likely influence StRAb binding by direct local effects rather than by globally modifying the conformational flexibility of HA. Our findings indicate that StRAb binding to HA is precarious, raising the possibility that sufficient immune pressure on the HA stem region could select for viral escape mutants with increased steric hindrance from N-linked glycans.
format Online
Article
Text
id pubmed-4055778
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40557782014-06-18 Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes Magadán, Javier G. Altman, Meghan O. Ince, William L. Hickman, Heather D. Stevens, James Chevalier, Aaron Baker, David Wilson, Patrick C. Ahmed, Rafi Bennink, Jack R. Yewdell, Jonathan W. PLoS Pathog Research Article Antigenic variation in the globular domain of influenza A virus (IAV) hemagglutinin (HA) precludes effective immunity to this major human pathogen. Although the HA stem is highly conserved between influenza virus strains, HA stem-reactive antibodies (StRAbs) were long considered biologically inert. It is now clear, however, that StRAbs reduce viral replication in animal models and protect against pathogenicity and death, supporting the potential of HA stem-based immunogens as drift-resistant vaccines. Optimally designing StRAb-inducing immunogens and understanding StRAb effector functions require thorough comprehension of HA stem structure and antigenicity. Here, we study the biogenesis of HA stem epitopes recognized in cells infected with various drifted IAV H1N1 strains using mouse and human StRAbs. Using a novel immunofluorescence (IF)-based assay, we find that human StRAbs bind monomeric HA in the endoplasmic reticulum (ER) and trimerized HA in the Golgi complex (GC) with similar high avidity, potentially good news for producing effective monomeric HA stem immunogens. Though HA stem epitopes are nestled among several N-linked oligosaccharides, glycosylation is not required for full antigenicity. Rather, as N-linked glycans increase in size during intracellular transport of HA through the GC, StRAb binding becomes temperature-sensitive, binding poorly to HA at 4°C and well at 37°C. A de novo designed, 65-residue protein binds the mature HA stem independently of temperature, consistent with a lack of N-linked oligosaccharide steric hindrance due to its small size. Likewise, StRAbs bind recombinant HA carrying simple N-linked glycans in a temperature-independent manner. Chemical cross-linking experiments show that N-linked oligosaccharides likely influence StRAb binding by direct local effects rather than by globally modifying the conformational flexibility of HA. Our findings indicate that StRAb binding to HA is precarious, raising the possibility that sufficient immune pressure on the HA stem region could select for viral escape mutants with increased steric hindrance from N-linked glycans. Public Library of Science 2014-06-12 /pmc/articles/PMC4055778/ /pubmed/24945804 http://dx.doi.org/10.1371/journal.ppat.1004204 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Magadán, Javier G.
Altman, Meghan O.
Ince, William L.
Hickman, Heather D.
Stevens, James
Chevalier, Aaron
Baker, David
Wilson, Patrick C.
Ahmed, Rafi
Bennink, Jack R.
Yewdell, Jonathan W.
Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
title Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
title_full Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
title_fullStr Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
title_full_unstemmed Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
title_short Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
title_sort biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055778/
https://www.ncbi.nlm.nih.gov/pubmed/24945804
http://dx.doi.org/10.1371/journal.ppat.1004204
work_keys_str_mv AT magadanjavierg biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT altmanmeghano biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT incewilliaml biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT hickmanheatherd biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT stevensjames biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT chevalieraaron biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT bakerdavid biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT wilsonpatrickc biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT ahmedrafi biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT benninkjackr biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT yewdelljonathanw biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes